Pleiotropic effects of statins - Test2 - elhamkhani - TriplyDB

Pleiotropic effects of statins

Pleiotropic effects of statins

http://www.wikidata.org/entity/Q24647863

about

Statin treatment increases lifespan and improves cardiac health in Drosophila by decreasing specific protein prenylation Breast ductal lavage for biomarker assessment in high risk women: rationale, design and methodology of a randomized phase II clinical trial with nimesulide, simvastatin and placebo Lipid-lowering efficacy of atorvastatin Lipid-lowering efficacy of rosuvastatin Statins for preventing colorectal adenoma and carcinoma Lipid lowering efficacy of atorvastatin Lipid lowering efficacy of rosuvastatin Lipid lowering efficacy of atorvastatin Cholesterol suppresses cellular TGF-beta responsiveness: implications in atherogenesis Mammalian Krüppel-like factors in health and diseases Fluvastatin for lowering lipids Pleiotropic effects of statins in the diseases of the liver The Trafficking of the Water Channel Aquaporin-2 in Renal Principal Cells-a Potential Target for Pharmacological Intervention in Cardiovascular Diseases Pleiotropic effects of statins Understanding the pathogenesis of abdominal aortic aneurysms Interactions between Autophagy and Bacterial Toxins: Targets for Therapy?Current controversies in the prediction, diagnosis, and management of cerebral vasospasm: where do we stand?Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease Treatment of dyslipidemia in allogeneic hematopoietic stem cell transplant patients Hyperlipidemia, tissue factor, coagulation, and simvastatin Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis Novel High Content Screen Detects Compounds That Promote Neurite Regeneration from Cochlear Spiral Ganglion Neurons.Targeting Nitric Oxide with Natural Derived Compounds as a Therapeutic Strategy in Vascular Diseases Granulomas and Inflammation: Host-Directed Therapies for Tuberculosis.Current and Emerging Uses of Statins in Clinical Therapeutics: A Review Immune Cell Regulatory Pathways Unexplored as Host-Directed Therapeutic Targets for Mycobacterium tuberculosis: An Opportunity to Apply Precision Medicine Innovations to Infectious Diseases Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endothelium Statins reduce the neurofibrillary tangle burden in a mouse model of tauopathy Commentary: From scarcity to abundance: pandemic vaccines and other agents for "have not" countries Nitric oxide synthases: regulation and function Geranylgeranyl diphosphate synthase: an emerging therapeutic target Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases Statins impair antitumor effects of rituximab by inducing conformational changes of CD20 Differential effects of pravastatin and simvastatin on the growth of tumor cells from different organ sites Plasma lipids and betaine are related in an acute coronary syndrome cohort Chemical and genetic validation of the statin drug target to treat the helminth disease, schistosomiasis RNA-sequencing analysis of HepG2 cells treated with atorvastatin Targeted delivery of lovastatin and tocotrienol to fracture site promotes fracture healing in osteoporosis model: micro-computed tomography and biomechanical evaluation Statins and Antimicrobial Effects: Simvastatin as a Potential Drug against Staphylococcus aureus Biofilm Simvastatin Sodium Salt and Fluvastatin Interact with Human Gap Junction Gamma-3 Protein

P2860

Q21090893-C6F1B196-4BD8-46F7-BD6D-575B2C505EA5 Q21261269-A8CE466C-E116-416B-A9B0-B45D0876ACD5 Q24187301-1DDF95A9-02CF-4823-A8E3-872A632E9DAE Q24187891-624E677F-461E-42A5-8E90-D0DFF09B8FDE Q24194802-A74F9A47-AEFD-4F21-A007-CBE8EBCA9F81 Q24202363-1B2EE238-F19F-4D9C-BA41-F3309CB1262E Q24202620-B4916C41-F2E8-47F8-9184-65F962B9B6A5 Q24241227-C9FF0433-CD32-4FF4-A948-CCE5AEC77749 Q24294300-3DD407A7-9881-4225-9205-57294BC00383 Q24612560-70F300E9-33B6-4854-996D-C2427B4D69FE Q26471262-02E0D169-8B11-4E2F-BF95-58E7C7D74046 Q26741176-D09D7676-8AF7-496C-BAB4-E918466C6A56 Q26768170-A06E23F6-47F8-4F9C-926A-DA4F487849AC Q26783220-94906826-8F58-495E-8792-0C8311A0AE4B Q26797277-C5893A71-67E3-4F3E-9FCC-7566A634A602 Q26801464-6F55A02C-9D75-4623-AA43-424C93720585 Q26823280-969015AA-7E92-42A2-AEC6-FE6E50347888 Q26859449-F510CA78-7847-483B-A478-2A3D591B26EB Q26996051-0B4A26EB-54C0-42AB-872B-708EFD380E27 Q27024964-3419B637-8221-4D3D-93C3-6639B62202DE Q27026250-F0211715-E9DA-4136-9E75-E877652FF0AB Q27307798-8C131454-E96E-45FE-B280-BC10F9BA9CFE Q28073279-61140282-B0A1-495C-9F3F-5D150A3DE0D1 Q28076037-3CFD3888-4F26-4088-B5F5-9BBE1CBFAFF6 Q28076346-F18AF485-B581-4F10-BCDB-D127CAC015E7 Q28081001-474FECC6-6E3C-4F23-80C6-E18EFBCC43A7 Q28219326-EBE437C8-B16D-4868-9E22-80E10A347857 Q28235507-2D01EF4A-BCFF-4C36-9CF0-AD723BD1B667 Q28242054-FCD14771-83AC-4E63-8AE6-774A87D274C4 Q28247092-F943E829-E8AE-4CC4-AA19-AC80CCE0D02E Q28252056-6238953F-E216-4A6C-864E-CBD04C552A4E Q28388335-EA6772D3-11F6-40A2-923C-D64893731E07 Q28472420-E05D0B64-6B89-41F0-B695-B226239D1AF9 Q28478551-BA0CDB3D-8395-4066-BC2E-649E4903BFF2 Q28478910-51DFE8B7-3122-422B-B175-AE56ED80272A Q28539314-A6079B73-823A-4D24-930F-B67A7319D50B Q28542543-3922EB81-AFF2-450B-87E4-22D5C9C477CA Q28542781-728E61A2-2777-4A42-8252-4C0254482405 Q28547567-BAF77DF3-E103-4B66-ACB6-469926B63598 Q28550067-50C9E1E2-924D-431A-9154-D422AB4AC2CD

P2860

Pleiotropic effects of statins

http://www.wikidata.org/entity/Q24647863

description

2005 nî lūn-bûn

@nan

2005 թուականին հրատարակուած գիտական յօդուած

@hyw

2005 թվականին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

name

Pleiotropic effects of statins

@ast

Pleiotropic effects of statins

@en

Pleiotropic effects of statins

@nl

type

label

Pleiotropic effects of statins

@ast

Pleiotropic effects of statins

@en

Pleiotropic effects of statins

@nl

prefLabel

Pleiotropic effects of statins

@ast

Pleiotropic effects of statins

@en

Pleiotropic effects of statins

@nl

P1433

Q24647863-0F98C4D6-7D74-4928-8261-B37D938CF4F9

P1476

Q24647863-3E05F3AF-01C1-467B-BAF4-B63A86ADB9BA

P2093

Q24647863-1469A383-B7E5-4092-8EA4-E140C3778138

Q24647863-4FFF183D-45BA-4908-8920-00B27C4DCDB1

P2860

Q24647863-0361CEFD-214E-4288-BC29-85E02E53DCA0

Q24647863-03E1CA4F-2ECE-48D1-BECE-A6120D023A72

Q24647863-05FA642F-CFB9-4541-8D2E-81EFDE6B50A3

Q24647863-07050A19-96ED-4EA3-97E9-5692702476E7

Q24647863-095BD50C-0C4E-49D6-927D-6E78B5E43962

Q24647863-0CB3F632-9DE2-491B-ACD5-9D7F404E648C

Q24647863-0E0BC958-8197-42B3-930E-97B46D2BFCB7

Q24647863-0FEA5E7D-41F2-4242-84B5-E88311FE6E72

Q24647863-12BB9C32-E6A9-40A3-83DE-D65798E8003F

Q24647863-15CDA389-E111-4BD0-8867-8B4F279E1C87

P304

Q24647863-A33EA44A-344A-4202-A714-A0A312042649

P31

Q24647863-2DA5108B-523A-43B3-8D06-368BAE5DDCAC

P3181

Q24647863-8CF99A10-C740-41DB-8638-46BD5E488B29

P356

Q24647863-55C8BE95-40D8-4961-8EDB-AD510F89A10A

P407

Q24647863-2C5E3D49-B983-4C02-9907-DAAD5BE50E53

P433

Q24647863-93FDE6DE-FE05-494E-A132-FA76C5A97A3C

P478

Q24647863-DA3BF700-9ED8-4039-8BB8-C5A6D836DF44

P577

Q24647863-B7A90A41-BE0A-48C0-93F7-DF038BA928A1

P5875

Q24647863-447FD1A0-C2A0-4DE9-BF65-F9FFE9F1D279

P698

Q24647863-8A9ADAF3-1512-4C87-A601-869F30297101

P932

Q24647863-175242CF-75C7-4023-B54F-9574359F82E9

P3181

P356

ANNUREV.PHARMTOX.45.120403.095748

P1433

Annual Review of Pharmacology and Toxicology

P1476

Pleiotropic effects of statins

@en

P2093

James K Liao

http://www.w3.org/2001/XMLSchema#string

Ulrich Laufs

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of endothelium-derived nitric oxide production by the protein kinase Akt

Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent

Structural mechanism for statin inhibition of HMG-CoA reductase

Rho GTPases and the actin cytoskeleton

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium

Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia

Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase

P304

89-118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1468872

http://www.w3.org/2001/XMLSchema#string

P356

10.1146/ANNUREV.PHARMTOX.45.120403.095748

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7914947

http://www.w3.org/2001/XMLSchema#string

P698

15822172

http://www.w3.org/2001/XMLSchema#string

P932

2694580

http://www.w3.org/2001/XMLSchema#string